SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-16-119538
Filing Date
2016-05-10
Accepted
2016-05-10 09:21:27
Documents
3
Period of Report
2016-05-10

Document Format Files

Seq Description Document Type Size
1 6-K a16-10318_26k.htm 6-K 16838
2 EX-99.1 a16-10318_2ex99d1.htm EX-99.1 152386
3 GRAPHIC g103182mm01i001.jpg GRAPHIC 10220
  Complete submission text file 0001104659-16-119538.txt   179015
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37558 | Film No.: 161633925
SIC: 2834 Pharmaceutical Preparations